@article{c962454d5a92482aa674c3de922126cb,
title = "Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database",
abstract = "To compare drug survival of different anti-TNF drugs (infliximab, INF, etanercept, ETA, and adalimumab, ADA) in rheumatoid arthritis (RA) and spondyloarthritis (SpA) by analysing data collected from an Italian multicenter observational cohort study.",
keywords = "rheumatoid arthritis, therapy, rheumatoid arthritis, therapy",
author = "Gianfranco Ferraccioli and Carlo.A. Scir{\`e} and Roberto Caporali and Piercarlo Sarzi-Puttini and Bruno Frediani and {Di Franco}, Manuela and Angela Tincani and Luigi Sinigaglia and Paolo Sfriso and Rosella Tirri and Emanuela Bellis and Giovanni Delsante and Giovanni Porru and Fausto Salafi and Dilia Giuggioli and Maurizio Rossini and Monica Todoerti and Laura Bazzichi and Marcello Govoni and Roberto Gerli and Roberto Raschetti and Giovanni Minisola and Carlomaurizio Montecucco and Silvano Todesco",
year = "2013",
language = "English",
volume = "31",
pages = "857--863",
journal = "CLINICAL AND EXPERIMENTAL RHEUMATOLOGY",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology:Via S Maria 31, I 56126 Pisa Italy:011 39 050 40124, EMAIL: info@clinexprhematol.org, INTERNET: http://www.clinexprhematol.org, Fax: 011 39 050 502299",
}